Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 17,489 | 16,088 | 12,615 | 11,360 | 8,942 |
| Cost of Goods | 7,123 | 8,665 | 7,259 | 6,572 | 5,181 |
| Gross Profit | 10,366 | 7,423 | 5,356 | 4,788 | 3,761 |
| Operating Expenses | 23,586 | 23,078 | 21,573 | 21,152 | 20,520 |
| Operating Income | -13,097 | -14,990 | -15,958 | -15,792 | -16,578 |
| Interest Expense | 1,507 | 1,451 | 1,299 | 1,136 | 1,060 |
| Other Income | 1,392 | 836 | 439 | 196 | 46 |
| Pre-tax Income | -13,212 | -15,605 | -16,818 | -16,732 | -17,592 |
| Income Tax | N/A | 5 | N/A | N/A | 4 |
| Net Income Continuous | -13,212 | -15,610 | -16,818 | -16,732 | -17,596 |
| Net Income | $-13,212 | $-15,610 | $-16,818 | $-16,732 | $-17,596 |
| EPS Basic Total Ops | -0.42 | -0.55 | -0.61 | -0.61 | -0.64 |
| EPS Basic Continuous Ops | -0.42 | -0.56 | -0.61 | -0.61 | -0.64 |
| EPS Diluted Total Ops | -0.42 | -0.55 | -0.61 | -0.61 | -0.64 |
| EPS Diluted Continuous Ops | -0.42 | -0.56 | -0.61 | -0.61 | -0.64 |
| EBITDA(a) | $-13,214 | $-14,668 | $-15,226 | $-14,795 | $-15,460 |